Correlation Between Scandinavian ChemoTech and ALM Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scandinavian ChemoTech and ALM Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scandinavian ChemoTech and ALM Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scandinavian ChemoTech AB and ALM Equity AB, you can compare the effects of market volatilities on Scandinavian ChemoTech and ALM Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scandinavian ChemoTech with a short position of ALM Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scandinavian ChemoTech and ALM Equity.

Diversification Opportunities for Scandinavian ChemoTech and ALM Equity

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Scandinavian and ALM is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Scandinavian ChemoTech AB and ALM Equity AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALM Equity AB and Scandinavian ChemoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scandinavian ChemoTech AB are associated (or correlated) with ALM Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALM Equity AB has no effect on the direction of Scandinavian ChemoTech i.e., Scandinavian ChemoTech and ALM Equity go up and down completely randomly.

Pair Corralation between Scandinavian ChemoTech and ALM Equity

Assuming the 90 days trading horizon Scandinavian ChemoTech AB is expected to under-perform the ALM Equity. In addition to that, Scandinavian ChemoTech is 5.92 times more volatile than ALM Equity AB. It trades about -0.01 of its total potential returns per unit of risk. ALM Equity AB is currently generating about 0.05 per unit of volatility. If you would invest  7,158  in ALM Equity AB on September 12, 2024 and sell it today you would earn a total of  1,372  from holding ALM Equity AB or generate 19.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Scandinavian ChemoTech AB  vs.  ALM Equity AB

 Performance 
       Timeline  
Scandinavian ChemoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scandinavian ChemoTech AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
ALM Equity AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALM Equity AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, ALM Equity is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Scandinavian ChemoTech and ALM Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scandinavian ChemoTech and ALM Equity

The main advantage of trading using opposite Scandinavian ChemoTech and ALM Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scandinavian ChemoTech position performs unexpectedly, ALM Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALM Equity will offset losses from the drop in ALM Equity's long position.
The idea behind Scandinavian ChemoTech AB and ALM Equity AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories